2021 Revenues ($USD) : $1,271,004,000
2021 R&D spend : $42,948,000
2021 Number of Employees : 7,900
Fiscal Year End : 12/31/2020
Key People : Vivek Jain, chair and CEO; Christian Voigtlander, COO; Dan Woolson, CVP and GM, infusion systems; Virginia Sanzone, CVP, general counsel; Brian Bonnell, CFO.

About the company: San Clemente, California–based ICU Medical develops and manufactures IV therapy devices for vascular therapy, oncology and critical care applications. Its devices include IV systems, closed system transfer devices, hemodynamic monitoring systems, cardiac output monitoring sensors and catheters, oximetry catheters, thermodilution and monitoring catheters, renal systems and more. ICU Medical acquired Hospira Infusion Systems from Pfizer in 2017 to exclusively focus on IV therapy. It’s set to grow even larger during the first half of 2022, when it expects to complete its $2.35 billion acquisition of Smiths Medical. –DK